Perinatal brain injury is a leading cause of death and disability in children. Hypoxic-ischemic encephalopathy in full term infants, and white matter injury in premature infants are most known brain injury in perinatal period. Human umbilical cord blood mononuclear cells contain hematopoietic stem cells, mesenchymal stem cells, endothelial progenitor cells, lymphocytes, monocytes, and so on. Human umbilical cord blood mononuclear cells have many biological functions, such as nerve and vascular regeneration, anti-apoptosis, anti-inflammation, and immune regulation. Human umbilical cord blood mononuclear cells transplantation has achieved significant efficacy and safety in animal and clinical trials for the treatment of perinatal brain injury. We will review human umbilical cord blood mononuclear cells transplantation for perinatal brain injury in this review.
CITATION STYLE
Xi, Y., Yue, G., Gao, S., Ju, R., & Wang, Y. (2022, December 1). Human umbilical cord blood mononuclear cells transplantation for perinatal brain injury. Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13287-022-03153-y
Mendeley helps you to discover research relevant for your work.